Complete Genomics performs whole human genome sequencing using proprietary biochemistry based on DNA nanoball arrays and combinatorial probe-anchor ligation sequencing. As these methods1 produce reads ...

Complete Genomics today announced the appointment of Edward T. McMullen Jr. to its Board of Directors, further strengthening the company's leadership in global business strategy, international ...

SAN JOSE, Calif. and MARCO ISLAND, Fla., Feb. 24, 2026 /PRNewswire/ -- Complete Genomics, a U.S.-based, innovator in genomic sequencing platforms and solutions, today announced it is commencing ...

Complete Genomics and Velsera are collaborating to deliver an end-to-end genetic testing solution that integrates DNBSEQ™ sequencing technology with Velsera’s Clinical Genomics Workspace (CGW) data ...

Complete Genomics, a small biotech based in Mountain View, California, started sequencing genomes in 2009, using a technology that produced minimal errors in whole genome reads, catching the attention ...

Complete Genomics will share details of various multi-omics and spatial transcriptomics applications based on its sequencing technology at the 2024 American Society of Human Genetics (ASHG) Meeting.

The DNBSEQ-T1+ is a next-generation mid-throughput sequencer that completes a paired end 150 sequencing workflow in just 24 hours with Q40 accuracy. With three flow cell formats, two to four ...

BOSTON, Nov. 11, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, today announced a collaboration with SOPHiA GENETICS (SOPH) (Nasdaq: SOPH), a global leader in ...

BASEL, Switzerland, October 28, 2025--(BUSINESS WIRE)--Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced today that they entered into a exclusive license agreement with MGI Tech and ...

An updated edition of the April 13, 2026, article. Genomics is the comprehensive study of genomes, the complete set of deoxyribonucleic acid (DNA) within an organism. Rapid scientific progress in this ...